Anika Therapeutics ANIK Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Anika Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Anika Therapeutics's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Anika Therapeutics's operating lease liabilities?
- Anika Therapeutics (ANIK) reported operating lease liabilities of $23.79M in Q1 2026.
- How has Anika Therapeutics's operating lease liabilities changed year-over-year?
- Anika Therapeutics's operating lease liabilities increased by 1.0% year-over-year, from $23.56M to $23.79M.
- What is the long-term trend for Anika Therapeutics's operating lease liabilities?
- Over 5 years (2020 to 2025), Anika Therapeutics's operating lease liabilities has grown at a 3.0% compound annual growth rate (CAGR), from $20.88M to $24.2M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.